Literature DB >> 6715358

Oxidized forms of parathyroid hormone with biological activity. Separation and characterization of hormone forms oxidized at methionine 8 and methionine 18.

A L Frelinger, J E Zull.   

Abstract

Bovine parathyroid hormone (PTH) was oxidized with hydrogen peroxide, and the oxidation products were separated by reverse phase high performance liquid chromatography. Using a shallow gradient, four major peaks (peaks I-IV in order of elution) were identified and completely separated from one another. Peak IV co-eluted with fully reduced PTH. The earliest eluting peak (peak I) could be reduced with mercaptoethylamine to produce all three of the later eluting ones. The second peak could be reduced back to peak IV but not to peak III, while peak III could be oxidized to peak I but not to peak II. These data plus the kinetics of oxidation showed that peaks II and III are intermediate in the generation of I from IV or IV from I, but were not generated from one another. Amino acid analysis showed that peak I contains no methionine and two residues of methionine sulfoxide, peaks II and III one methionine sulfoxide each, and peak IV two residues of methionine and no sulfoxide. Study of the peptides produced from each form of PTH by cleavage with cyanogen bromide showed that peak II is oxidized at methionine 8 and peak III at methionine 18 while peak I is oxidized at both methionines. The biological activity of each peak was determined in the kidney membrane adenylyl cyclase assay. All forms were active but with widely varying potencies (peak IV greater than peak III greater than peak II greater than peak I).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715358

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

2.  Oxidation of recombinant human parathyroid hormone: effect of oxidized position on the biological activity.

Authors:  Y Nabuchi; E Fujiwara; K Ueno; H Kuboniwa; Y Asoh; H Ushio
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Demonstrated solid-state stability of parathyroid hormone PTH(1-34) coated on a novel transdermal microprojection delivery system.

Authors:  Mahmoud Ameri; Peter E Daddona; Yuh-Fun Maa
Journal:  Pharm Res       Date:  2009-11       Impact factor: 4.200

4.  Oxidation inhibits PTH receptor signaling and trafficking.

Authors:  Juan A Ardura; Verónica Alonso; Pedro Esbrit; Peter A Friedman
Journal:  Biochem Biophys Res Commun       Date:  2016-11-28       Impact factor: 3.575

5.  The stability and degradation pathway of recombinant human parathyroid hormone: deamidation of asparaginyl residue and peptide bond cleavage at aspartyl and asparaginyl residues.

Authors:  Y Nabuchi; E Fujiwara; H Kuboniwa; Y Asoh; H Ushio
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

6.  Isolation and characterization of a monomethioninesulfoxide variant of interferon alpha-2b.

Authors:  G Gitlin; A Tsarbopoulos; S T Patel; W Sydor; B N Pramanik; S Jacobs; L Westreich; S Mittelman; J N Bausch
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

7.  Effects of antioxidants on the hydrogen peroxide-mediated oxidation of methionine residues in granulocyte colony-stimulating factor and human parathyroid hormone fragment 13-34.

Authors:  Jin Yin; Jhih-Wei Chu; Margaret Speed Ricci; David N Brems; Daniel I C Wang; Bernhardt L Trout
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

8.  Mutation of Methionine to Asparagine but Not Leucine in Parathyroid Hormone Mimics the Loss of Biological Function upon Oxidation.

Authors:  Amit Gaur; Jessica Lipponen; Yanmei Yang; Roger S Armen; Bin Wang
Journal:  Biochemistry       Date:  2022-05-09       Impact factor: 3.321

9.  Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.

Authors:  G J Strewler; P H Stern; J W Jacobs; J Eveloff; R F Klein; S C Leung; M Rosenblatt; R A Nissenson
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

10.  Development and validation of RP-HPLC and RP-UPLC methods for quantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol.

Authors:  Shaligram S Rane; Alkesh Ajameri; Rustom Mody; P Padmaja
Journal:  J Pharm Anal       Date:  2011-12-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.